Cargando…

ALKBH5 suppresses malignancy of hepatocellular carcinoma via m(6)A-guided epigenetic inhibition of LYPD1

BACKGROUND: N6-methyladenosine (m(6)A) modification is an emerging layer of epigenetic regulation which is widely implicated in the tumorigenicity of hepatocellular carcinoma (HCC), offering a novel perspective for investigating molecular pathogenesis of this disease. The role of AlkB homolog 5 (ALK...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Yunhao, Zhao, Yanchun, Chen, Junru, Peng, Chuanhui, Zhang, Yanpeng, Tong, Rongliang, Cheng, Qiyang, Yang, Beng, Feng, Xiaode, Lu, Yuejie, Xie, Haiyang, Zhou, Lin, Wu, Jian, Zheng, Shusen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7416417/ https://www.ncbi.nlm.nih.gov/pubmed/32772918 http://dx.doi.org/10.1186/s12943-020-01239-w

Ejemplares similares

High-metastatic cancer cells derived exosomal miR92a-3p promotes epithelial-mesenchymal transition and metastasis of low-metastatic cancer cells by regulating PTEN/Akt pathway in hepatocellular carcinoma
por: Yang, Beng, et al.
Publicado: (2020)

ACSL4 promotes hepatocellular carcinoma progression via c-Myc stability mediated by ERK/FBW7/c-Myc axis
por: Chen, Junru, et al.
Publicado: (2020)

WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1
por: Chen, Yunhao, et al.
Publicado: (2019)

RBM15 promotes hepatocellular carcinoma progression by regulating N6-methyladenosine modification of YES1 mRNA in an IGF2BP1-dependent manner
por: Cai, Xianlei, et al.
Publicado: (2021)

m(6)A-modification regulated circ-CCT3 acts as the sponge of miR-378a-3p to promote hepatocellular carcinoma progression
por: Liu, Hua, et al.
Publicado: (2023)

KCTD11 inhibits growth and metastasis of hepatocellular carcinoma through activating Hippo signaling
por: Tong, Rongliang, et al.
Publicado: (2017)

miR-424-5p represses the metastasis and invasion of intrahepatic cholangiocarcinoma by targeting ARK5
por: Wu, Jingbang, et al.
Publicado: (2019)

Mitochondrial TSPO Promotes Hepatocellular Carcinoma Progression through Ferroptosis Inhibition and Immune Evasion
por: Zhang, Deguo, et al.
Publicado: (2023)

Functional interaction between Lypd6 and nicotinic acetylcholine receptors
por: Arvaniti, Maria, et al.
Publicado: (2016)

Human LYPD8 protein inhibits motility of flagellated bacteria
por: Hsu, Chiao-Ching, et al.
Publicado: (2017)

Spontaneous rupture of solid pseudopapillary tumor of pancreas: A case report and review of literature
por: Xu, Xiaofeng, et al.
Publicado: (2019)

Left-side vs. right-side hepatectomy for hilar cholangiocarcinoma: a meta-analysis
por: Wu, Wenxuan, et al.
Publicado: (2021)

The HDAC Inhibitor Quisinostat (JNJ-26481585) Supresses Hepatocellular Carcinoma alone and Synergistically in Combination with Sorafenib by G0/G1 phase arrest and Apoptosis induction
por: He, Bin, et al.
Publicado: (2018)

γ-H2AX promotes hepatocellular carcinoma angiogenesis via EGFR/HIF-1α/VEGF pathways under hypoxic condition
por: Xiao, Heng, et al.
Publicado: (2014)

Over Expression of Long Non-Coding RNA PANDA Promotes Hepatocellular Carcinoma by Inhibiting Senescence Associated Inflammatory Factor IL8
por: Peng, Chuanhui, et al.
Publicado: (2017)

Heart-derived fibroblasts express LYPD-1 and negatively regulate angiogenesis in rat
por: Sakamoto, Satoru, et al.
Publicado: (2020)

LYPD3, a New Biomarker and Therapeutic Target for Acute Myelogenous Leukemia
por: Hu, Tingting, et al.
Publicado: (2022)

Targeting Mybbp1a suppresses HCC progression via inhibiting IGF1/AKT pathway by CpG islands hypo-methylation dependent promotion of IGFBP5
por: Weng, Xiaoyu, et al.
Publicado: (2019)

Expression and Critical Role of Interleukin Enhancer Binding Factor 2 in Hepatocellular Carcinoma
por: Cheng, Shaobing, et al.
Publicado: (2016)

Human Three-Finger Protein Lypd6 Is a Negative Modulator of the Cholinergic System in the Brain
por: Kulbatskii, Dmitrii, et al.
Publicado: (2021)

Identification of GPI-anchored protein LYPD1 as an essential factor for odontoblast differentiation in tooth development
por: Fu, Yao, et al.
Publicado: (2023)

The crosstalk between m(6)A RNA methylation and other epigenetic regulators: a novel perspective in epigenetic remodeling
por: Zhao, Yanchun, et al.
Publicado: (2021)

Impact of donor age on liver transplant outcomes in patients with hepatocellular carcinoma: analysis of the SRTR database
por: Zhou, Jie, et al.
Publicado: (2021)

H2A.Z regulates tumorigenesis, metastasis and sensitivity to cisplatin in intrahepatic cholangiocarcinoma
por: Yang, Beng, et al.
Publicado: (2018)

LYPD8 regulates the proliferation and migration of colorectal cancer cells through inhibiting the secretion of IL-6 and TNF-α
por: Xu, Jianbin, et al.
Publicado: (2021)

LncRNA ALKBH3‐AS1 enhances ALKBH3 mRNA stability to promote hepatocellular carcinoma cell proliferation and invasion
por: Lu, Qiliang, et al.
Publicado: (2022)

Structural insights into the interactions and epigenetic functions of human nucleic acid repair protein ALKBH6
por: Ma, Lulu, et al.
Publicado: (2022)

β2-Adrenergic Signalling Promotes Cell Migration by Upregulating Expression of the Metastasis-Associated Molecule LYPD3
por: Gruet, Michael, et al.
Publicado: (2020)

GluR2(Q) and GluR2(R) AMPA Subunits are not Targets of lypd2 Interaction
por: Lauriello, Anna, et al.
Publicado: (2022)

GATA6 regulates anti-angiogenic properties in human cardiac fibroblasts via modulating LYPD1 expression
por: Masuda, Shinako, et al.
Publicado: (2023)

BAG3 and HIF-1α Coexpression Detected by Immunohistochemistry Correlated with Prognosis in Hepatocellular Carcinoma after Liver Transplantation
por: Xiao, Heng, et al.
Publicado: (2014)

A Critical Role for ZDHHC2 in Metastasis and Recurrence in Human Hepatocellular Carcinoma
por: Peng, Chuanhui, et al.
Publicado: (2014)

AG-1024 Sensitizes Sorafenib-Resistant Hepatocellular Carcinoma Cells to Sorafenib via Enhancing G1/S Arrest
por: Zhou, Wei, et al.
Publicado: (2021)

LY6/PLAUR domain containing 3 (LYPD3) maintains melanoma cell stemness and mediates an immunosuppressive microenvironment
por: Hu, Yi-dou, et al.
Publicado: (2023)

ACADS acts as a potential methylation biomarker associated with the proliferation and metastasis of hepatocellular carcinomas
por: Chen, Diyu, et al.
Publicado: (2019)

A positive-feedback loop between HBx and ALKBH5 promotes hepatocellular carcinogenesis
por: Qu, Siming, et al.
Publicado: (2021)

Sequence Dependent Repair of 1,N(6)-Ethenoadenine by DNA Repair Enzymes ALKBH2, ALKBH3, and AlkB
por: Qi, Rui, et al.
Publicado: (2021)

Atypical hemangioma mimicking mixed hepatocellular cholangiocarcinoma: Case report
por: Lin, Shengzhang, et al.
Publicado: (2017)

ALKBH5 prevents hepatocellular carcinoma progression by post-transcriptional inhibition of PAQR4 in an m6A dependent manner
por: Wang, Weijian, et al.
Publicado: (2023)

ALKBH5-mediated CHAC1 depletion promotes malignant progression and decreases cisplatin-induced oxidative stress in gastric cancer
por: Chen, Chunting, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_21ugdg9l7rnu85ctg8av7l75ot